1 Chait A, den Hartigh LJ. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front Cardiovasc Med 2020;7:22.
2 Guilherme A, Virbasius JV, Puri V, et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008;9:367–77.
3 Stefanovic-Racic M, Yang X, Turner MS, et al. Dendritic cells promote macrophage infiltration and comprise a substantial proportion of obesity-associated increases in CD11c+ cells in adipose tissue and liver. Diabetes 2012;61:2330–9.
4 Yamashita A, Soga Y, Iwamoto Y, et al. Macrophage-adipocyte interaction: marked interleukin-6 production by lipopolysaccharide. Obesity 2007;15:2549–52.
5 Yan Y, Chen R, Wang X, et al. Ccl19 and CCR7 expression, signaling pathways, and adjuvant functions in viral infection and prevention. Front Cell Dev Biol 2019;7:212.
6 Xuan W, Qu Q, Zheng B, et al. The chemotaxis of M1 and M2 macrophages is regulated by different chemokines. J Leukoc Biol 2015;97:61–9.
7 Rodríguez-Fernández JL, Criado-García O. The chemokine receptor CCR7 uses distinct signaling modules with biased functionality to regulate dendritic cells. Front Immunol 2020;11:528.
8 Sano T, Iwashita M, Nagayasu S, et al. Protection from diet-induced obesity and insulin resistance in mice lacking CCL19-CCR7 signaling. Obesity 2015;23:1460–71.
9 Steen A, Larsen O, Thiele S, et al. Biased and G protein-independent signaling of chemokine receptors. Front Immunol 2014;5:277.
10 Jørgensen AS, Adogamhe PE, Laufer JM, et al. Ccl19 with CCL21-tail displays enhanced glycosaminoglycan binding with retained chemotactic potency in dendritic cells. J Leukoc Biol 2018;104:401–11.
11 Cho KW, Zamarron BF, Muir LA, et al. Adipose tissue dendritic cells are independent contributors to obesity-induced inflammation and insulin resistance. J Immunol 2016;197:3650–61.
12 Hellmann J, Sansbury BE, Holden CR, et al. Ccr7 maintains Nonresolving lymph node and adipose inflammation in obesity. Diabetes 2016;65:2268–81.
13 Orr JS, Kennedy AJ, Hill AA, et al. Cc-Chemokine receptor 7 (CCR7) deficiency alters adipose tissue leukocyte populations in mice. Physiol Rep 2016;4:e12971.
14 Kitahara CM, Trabert B, Katki HA, et al. Body mass index, physical activity, and serum markers of inflammation, immunity, and insulin resistance. Cancer Epidemiol Biomarkers Prev 2014;23:2840–9.
15 Kochumon S, Al-Rashed F, Abu-Farha M, et al. Adipose tissue expression of CCL19 chemokine is positively associated with insulin resistance. Diabetes Metab Res Rev 2019;35:e3087.
16 Nakano H, Gunn MD. Gene duplications at the chemokine locus on mouse chromosome 4: multiple strain-specific haplotypes and the deletion of secondary lymphoid-organ chemokine and EBI-1 ligand chemokine genes in the pLT mutation. J Immunol 2001;166:361–9.
17 Mori S, Nakano H, Aritomi K, et al. Mice lacking expression of the chemokines CCL21-ser and CCL19 (pLT mice) demonstrate delayed but enhanced T cell immune responses. J Exp Med 2001;193:207–18.
18 López-Cotarelo P, Escribano-Díaz C, González-Bethencourt IL, et al. A novel MEK-ERK-AMPK signaling axis controls chemokine receptor CCR7-dependent survival in human mature dendritic cells. J Biol Chem 2015;290:827–40.
19 Hwang S-L, Jeong Y-T, Li X, et al. Inhibitory cross-talk between the AMPK and ERK pathways mediates endoplasmic reticulum stress-induced insulin resistance in skeletal muscle. Br J Pharmacol 2013;169:69–81.
20 Day EA, Ford RJ, Steinberg GR. Ampk as a therapeutic target for treating metabolic diseases. Trends Endocrinol Metab 2017;28:545–60.
21 O'Neill HM, Holloway GP, Steinberg GR. Ampk regulation of fatty acid metabolism and mitochondrial biogenesis: implications for obesity. Mol Cell Endocrinol 2013;366:135–51.
22 Oakhill JS, Chen Z-P, Scott JW, et al. -Subunit myristoylation is the gatekeeper for initiating metabolic stress sensing by AMP- activated protein kinase (AMPK). Proc Natl Acad Sci U S A 2010;107:19237–41.
23 Cantó C, Gerhart-Hines Z, Feige JN, et al. Ampk regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 2009;458:1056–60.
24 Betz MJ, Enerbäck S. Human brown adipose tissue: what we have learned so far. Diabetes 2015;64:2352–60.
25 Fernandez-Marcos PJ, Auwerx J. Regulation of PGC-1, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr 2011;93:884S–90.
26 Kleiner S, Mepani RJ, Laznik D, et al. Development of insulin resistance in mice lacking PGC-1 in adipose tissues. Proc Natl Acad Sci U S A 2012;109:9635–40.
27 Tian D, Hong H, Shang W, et al. Deletion of Ppard in CD11c+ cells attenuates atherosclerosis in ApoE knockout mice. Faseb J 2020;34:3367–78.
28 Iwashita M, Sakoda H, Kushiyama A, et al. Valsartan, independently of AT1 receptor or PPAR, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes. Am J Physiol Endocrinol Metab 2012;302:E286–96.
29 Hasegawa Y, Hoshino Y, Ibrahim AE, et al. Generation of CRISPR/ Cas9-mediated bicistronic knock-in ins1-cre driver mice. Exp Anim 2016;65:319–27.
30 Ogawa Y, Imajo K, Honda Y, et al. Palmitate-Induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin. Sci Rep 2018;8:11365.
31 Takato T, Iwata K, Murakami C, et al. Chronic administration of myristic acid improves hyperglycaemia in the Nagoya-Shibata- Yasuda mouse model of congenital type 2 diabetes. Diabetologia 2017;60:2076–83.
32 Martinez-Santibañez G, Cho KW, Lumeng CN. Imaging white adipose tissue with confocal microscopy. Methods Enzymol 2014;537:17–30.
33 Matsunaga H, Iwashita M, Shinjo T, et al. Adipose tissue complement factor B promotes adipocyte maturation. Biochem Biophys Res Commun 2018;495:740–8.
34 Stelzner K, Herbert D, Popkova Y, et al. Free fatty acids sensitize dendritic cells to amplify TH1/TH17-immune responses. Eur J Immunol 2016;46:2043–53.
35 Hong S, Song W, Zushin P-JH, et al. Phosphorylation of beta- 3 adrenergic receptor at serine 247 by ERK MAP kinase drives lipolysis in obese adipocytes. Mol Metab 2018;12:25–38.
36 Ozaki K-I, Awazu M, Tamiya M, et al. Targeting the ERK signaling pathway as a potential treatment for insulin resistance and type 2 diabetes. Am J Physiol Endocrinol Metab 2016;310:E643–51.
37 Tsukumo DML, Carvalho-Filho MA, Carvalheira JBC, et al. Loss- of-Function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007;56:1986–98.
38 Shi H, Kokoeva MV, Inouye K, et al. Tlr4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006;116:3015–25.
39 Sidossis L, Kajimura S. Brown and beige fat in humans: thermogenic adipocytes that control energy and glucose homeostasis. J Clin Invest 2015;125:478–86.
40 Ikeda K, Maretich P, Kajimura S. The common and distinct features of brown and beige adipocytes. Trend Endocrinol Metab 2018;29:191–200.
41 Mottillo EP, Desjardins EM, Crane JD, et al. Lack of adipocyte AMPK exacerbates insulin resistance and hepatic steatosis through brown and beige adipose tissue function. Cell Metab 2016;24:118–29.
42 Xu XJ, Gauthier M-S, Hess DT, et al. Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot- specific changes in gene expression in adipose tissue. J Lipid Res 2012;53:792–801.
43 Ruderman NB, Xu XJ, Nelson L, et al. Ampk and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab 2010;298:E751–60.
44 Ruderman NB, Carling D, Prentki M, et al. Ampk, insulin resistance, and the metabolic syndrome. J Clin Invest 2013;123:2764–72.
45 Lindholm CR, Ertel RL, Bauwens JD, et al. A high-fat diet decreases AMPK activity in multiple tissues in the absence of hyperglycemia or systemic inflammation in rats. J Physiol Biochem 2013;69:165–75.
46 Luo T, Nocon A, Fry J, et al. Ampk activation by metformin suppresses abnormal extracellular matrix remodeling in adipose tissue and ameliorates insulin resistance in obesity. Diabetes 2016;65:2295–310.
47 Sano T, Sanada T, Sotomaru Y, et al. Ccr7 null mice are protected against diet-induced obesity via UCP1 upregulation and enhanced energy expenditure. Nutr Metab 2019;16:43.
48 Sakamoto T, Nitta T, Maruno K, et al. Macrophage infiltration into obese adipose tissues suppresses the induction of UCP1 level in mice. Am J Physiol Endocrinol Metab 2016;310:E676–87.
49 Nøhr MK, Bobba N, Richelsen B, et al. Inflammation downregulates UCP1 expression in brown adipocytes potentially via SIRT1 and DBC1 interaction. Int J Mol Sci 2017;18:1006.
50 Yang Z, Kahn BB, Shi H, et al. Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J Biol Chem 2010;285:19051–9.
51 Carroll KC, Viollet B, Suttles J. Ampk1 deficiency amplifies proinflammatory myeloid APC activity and CD40 signaling. J Leukoc Biol 2013;94:1113–21.
52 Munenaga Y, Yamashina T, et al, Hiroshima Study Group. Improvement of glycated hemoglobin in Japanese subjects with type 2 diabetes by resolution of periodontal inflammation using adjunct topical antibiotics: results from the Hiroshima study. Diabetes Res Clin Pract 2013;100:53–60.
53 Offenbacher S, Beck JD, Moss K, et al. Results from the periodontitis and vascular events (pave) study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodontol 2009;80:190–201.
54 Slade GD, Ghezzi EM, Heiss G, et al. Relationship between periodontal disease and C-reactive protein among adults in the Atherosclerosis risk in Communities study. Arch Intern Med 2003;163:1172–9.
55 Araneta MRG, Kanaya AM, Hsu WC, et al. Optimum BMI cut points to screen Asian Americans for type 2 diabetes. Diabetes Care 2015;38:814–20.
論文の公開元へ
